Matches in SemOpenAlex for { <https://semopenalex.org/work/W2413921352> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2413921352 endingPage "38" @default.
- W2413921352 startingPage "32" @default.
- W2413921352 abstract "Aim To study histological, clinical features and prognosis in patients with fatty hepatosis (FH) and non-alcoholic steatohepatitis (NASH). Material and methods Clinical and laboratory data on 74 patients with FH of non-alcoholic origin were studied. All the patients have undergone puncture biopsy of the liver (a total of 91 biopsies). Patients with fatty dystrophy of the first, second and third degree and fibrosis of the first and second degree entered the group of fatty hepatosis without inflammation (group 1, n = 54), patients with fatty dystrophy of the second and third degree and fibrosis of the third degree were assigned to group 2 (n = 20), i.e. to the group of FH with inflammation. The latter group by modern histological characteristics belongs to NASH. Results Functional disorders of the liver were insignificant, urobilinogenuria, delayed retention of bromsulphalein, hypertriglyceridemia were observed. AlAT activity was insignificantly elevated in FH patients. It was elevated 1.5-2.5-fold in NASH, the activity of AsAT, gamma-GTP was high in half of the patients. NASH has no specific clinico-biochemical signs and its diagnosis is based on the data of puncture biopsy of the liver. Long-term follow-up of 42 patients with FH and NASH discovered stabilization of the process in 34 patients. Cirrhosis of the liver occurred in 5 patients. Repeated biopsies established association of fatty dystrophy with developing micronodular cirrhosis. Conclusion NASH is an independent disease. This should be taken into consideration in differential diagnosis in patients with a stable rise of serum activity of AlAT and AsAT, especially in obesity, diabetes, hyperlipidemia. The diagnosis is verified at biopsy of the liver. In spite of scare symptoms, long-term follow-up detects progression of the disease in more than 1/3 of the patients. Cirrhosis arose in 1/6 of the patients. Standard NASH treatment is absent, though elimination of the provoking factors, therapy with antioxidant drugs and ursodesoxycholic acid produce a favourable effect." @default.
- W2413921352 created "2016-06-24" @default.
- W2413921352 creator A5075840893 @default.
- W2413921352 date "2006-01-01" @default.
- W2413921352 modified "2023-09-24" @default.
- W2413921352 title "[Fatty hepatosis. Non-alcoholic steatohepatitis (evolution of the knowledge about clinico-morphological features, prognosis, treatment)]." @default.
- W2413921352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16821419" @default.
- W2413921352 hasPublicationYear "2006" @default.
- W2413921352 type Work @default.
- W2413921352 sameAs 2413921352 @default.
- W2413921352 citedByCount "0" @default.
- W2413921352 crossrefType "journal-article" @default.
- W2413921352 hasAuthorship W2413921352A5075840893 @default.
- W2413921352 hasConcept C126322002 @default.
- W2413921352 hasConcept C142724271 @default.
- W2413921352 hasConcept C2775934546 @default.
- W2413921352 hasConcept C2777017193 @default.
- W2413921352 hasConcept C2777214474 @default.
- W2413921352 hasConcept C2777766500 @default.
- W2413921352 hasConcept C2778772119 @default.
- W2413921352 hasConcept C2779134260 @default.
- W2413921352 hasConcept C2779478299 @default.
- W2413921352 hasConcept C2780559512 @default.
- W2413921352 hasConcept C71924100 @default.
- W2413921352 hasConcept C90924648 @default.
- W2413921352 hasConceptScore W2413921352C126322002 @default.
- W2413921352 hasConceptScore W2413921352C142724271 @default.
- W2413921352 hasConceptScore W2413921352C2775934546 @default.
- W2413921352 hasConceptScore W2413921352C2777017193 @default.
- W2413921352 hasConceptScore W2413921352C2777214474 @default.
- W2413921352 hasConceptScore W2413921352C2777766500 @default.
- W2413921352 hasConceptScore W2413921352C2778772119 @default.
- W2413921352 hasConceptScore W2413921352C2779134260 @default.
- W2413921352 hasConceptScore W2413921352C2779478299 @default.
- W2413921352 hasConceptScore W2413921352C2780559512 @default.
- W2413921352 hasConceptScore W2413921352C71924100 @default.
- W2413921352 hasConceptScore W2413921352C90924648 @default.
- W2413921352 hasIssue "4" @default.
- W2413921352 hasLocation W24139213521 @default.
- W2413921352 hasLocation W24139213522 @default.
- W2413921352 hasOpenAccess W2413921352 @default.
- W2413921352 hasPrimaryLocation W24139213521 @default.
- W2413921352 hasRelatedWork W103573474 @default.
- W2413921352 hasRelatedWork W125645256 @default.
- W2413921352 hasRelatedWork W1433606059 @default.
- W2413921352 hasRelatedWork W1969660985 @default.
- W2413921352 hasRelatedWork W1992655618 @default.
- W2413921352 hasRelatedWork W2039398567 @default.
- W2413921352 hasRelatedWork W2047753762 @default.
- W2413921352 hasRelatedWork W2050527566 @default.
- W2413921352 hasRelatedWork W2074874601 @default.
- W2413921352 hasRelatedWork W2079071183 @default.
- W2413921352 hasRelatedWork W2098635799 @default.
- W2413921352 hasRelatedWork W2103265067 @default.
- W2413921352 hasRelatedWork W2268663218 @default.
- W2413921352 hasRelatedWork W2783781914 @default.
- W2413921352 hasRelatedWork W2942170251 @default.
- W2413921352 hasRelatedWork W2960659142 @default.
- W2413921352 hasRelatedWork W2989974125 @default.
- W2413921352 hasRelatedWork W3158373260 @default.
- W2413921352 hasRelatedWork W93558354 @default.
- W2413921352 hasRelatedWork W2373641615 @default.
- W2413921352 hasVolume "78" @default.
- W2413921352 isParatext "false" @default.
- W2413921352 isRetracted "false" @default.
- W2413921352 magId "2413921352" @default.
- W2413921352 workType "article" @default.